论文信息 - The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer - 字舞流文

The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer

B. Sancak | S. Buyukberber | U. Coşkun | R. Yıldız | M. Benekli | V. Berk | D. Yamaç | B. Ozturk | E. Yaman | A. Uner | A. Kaya